Document:

Exhibit 10.9

 

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS
PURCHASE AGREEMENT, dated as of [ ], 2022 (as it may from time to time be amended, this “Agreement”), is entered into
by and between Virtuoso Acquisition Corp. 2, a Delaware corporation (the “Company”) and Cantor Fitzgerald & Co.
(the “Purchaser”).

 

WHEREAS, the Company intends
to consummate an initial public offering of the Company’s units (the “Public Offering”), each unit consisting
of one share (each, a “Share”) of Class A common stock of the Company, par value $0.0001 per share (the “Common
Stock”), and one-third of one redeemable warrant;

 

WHEREAS, each whole warrant
entitles the holder to purchase one Share at an exercise price of $11.50 per Share; and

 

WHEREAS, the Purchaser has agreed
to purchase an aggregate of 333,334 warrants (or up to 383,334 warrants to the extent the underwriters’ over-allotment option is
exercised) (the “Private Placement Warrants”), each Private Placement Warrant entitling the holder to purchase one
Share at an exercise price of $11.50 per Share.

 

NOW, THEREFORE, in consideration
of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1. Authorization, Purchase and Sale; Terms of the Private
Placement Warrants.

 

A.    Authorization
of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement Warrants to the
Purchaser.

 

B.    Purchase
and Sale of the Private Placement Warrants.

 

(i)    Simultaneously
with the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the Company
(the “Initial Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from
the Company, an aggregate of 333,334 Private Placement Warrants at a price of $1.50 per warrant for an aggregate purchase price of $500,001
(the “Purchase Price”). Purchaser shall pay the Purchase Price by wire transfer of immediately available funds to the
trust account (the “Trust Account”) maintained by Continental Stock Transfer & Trust Company, acting as trustee
(“Continental”), on the Initial Closing Date. On the Initial Closing Date, upon the payment by the Purchaser of the
Purchase Price, the Company, at its option, shall deliver a certificate evidencing the Private Placement Warrants purchased on such date
duly registered in the Purchaser’s name to the Purchaser or effect such delivery in book-entry form.

 

     

     

    

 

(ii)    In
the event that the underwriters’ over-allotment option is exercised in full or in part, the Purchaser shall purchase up to an additional
50,000 Private Placement Warrants (the “Additional Private Placement Warrants”), in the same proportion as the amount
of the option that is so exercised, and simultaneously with such purchase of Additional Private Placement Warrants, as payment in full
for the Additional Private Placement Warrants being purchased hereunder, and on the date of the closing of such portion of the underwriters’
over-allotment option, Purchaser shall pay $1.50 per Additional Private Placement Warrant, up to an aggregate amount of $75,000 by wire
transfer of immediately available funds or by such other method as may be reasonably acceptable to the Company, to the Trust Account.
The closing of the purchase and sale of the Additional Private Placement Warrants, if applicable, shall take place simultaneously with
the closing of all or any portion of the underwriters’ over-allotment option (such closing date, together with the Initial Closing
Date, the “Closing Dates” and each, a “Closing Date”). The closing of the purchase and sale of the
Additional Private Placement Warrants, if applicable, shall take place at the offices of Arnold & Porter Kaye Scholer LLP, counsel
for the Company, or such other place as may be agreed upon by the parties hereto.

 

C.    Terms
of the Private Placement Warrants.

 

(i)    Each
Private Placement Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company and Continental in connection
with the Public Offering (the “Warrant Agreement”).

 

(ii)    In
addition to such other terms, conditions and restrictions set forth in the Warrant Agreement and as set forth herein, the Purchaser agrees
that it shall not Transfer (as defined below) any Private Placement Warrants (or shares of Common Stock issued or issuable upon the exercise
of the Private Placement Warrants) until 30 days after the completion of a Business Combination (as defined below) (such 30-day period,
the “Lock-up Period”). Notwithstanding the foregoing, Transfers of the Private Placement Warrants and the shares of
Common Stock issued or issuable upon the exercise thereof and that are held by the Purchaser or any of its permitted transferees are permitted:
(a) to the Company’s officers or directors, any affiliate or family member of any of the Company’s officers or directors,
or to any member(s) of Virtuoso Sponsor 2 LLC (the “Sponsor”) or any affiliates of the Sponsor, Cantor or Group LP;
(b) in the case of an individual, by gift to a member of one of the members of the individual’s immediate family or to a trust,
the beneficiary of which is a member of one of the individual’s immediate family, an affiliate of such person or to a charitable
organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the
case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or Transfers made in connection with the
consummation of an initial Business Combination at prices no greater than the price at which the Shares or Private Placement Warrants
were originally purchased; (f) in the event of the Company’s liquidation prior to the completion of an initial Business Combination;
or (g) in the event of the Company’s liquidation, merger, capital stock exchange, reorganization or other similar transaction which
results in all of its stockholders having the right to exchange their shares of Common Stock for cash, securities or other property subsequent
to the completion of the Business Combination; provided, however, that in the case of clauses (a) through (e), these permitted transferees
must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions herein. For purposes hereof:

 

(A)   “Business
Combination” shall mean a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination, involving the Company and one or more businesses; and

 

    2

    

    

 

(B)   “Transfer”
shall mean the (1) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise
dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation
with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as
amended, and the rules and regulations of the Securities and Exchange Commission promulgated thereunder with respect to, any security,
(2) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (3) public announcement
of any intention to effect any transaction specified in clause (1) or (2).

 

(iii)   On
or prior to the date of effectiveness (the “Effective Date”) of the registration statement relating to the Public Offering
(the “Registration Statement”), the Company and the Purchaser shall enter into a registration and shareholder rights
agreement (the “Registration and Shareholder Rights Agreement”) pursuant to which the Company will grant certain registration
rights to the Purchaser relating to the Private Placement Warrants and the Shares underlying the Private Placement Warrants.

 

(iv)   The
Purchaser acknowledges and agrees that the Private Placement Warrants and the related registration rights will be deemed compensation
by the Financial Industry Regulatory Authority (“FINRA”) and will therefore, pursuant to Rule 5110(e) of
the FINRA Manual, be subject to lock-up for a period of 180 days immediately following the commencement of sales of the Public Offering,
subject to FINRA Rule 5110(e)(2). The Private Placement Warrants, the Shares issuable upon the exercise of the Private Placement
Warrants, and the related registration rights may not be sold, transferred, assigned, pledged or hypothecated or be the subject of any
hedging, short sale, derivative, put or call transaction that would result in the economic disposition of such securities by any person
during the foregoing 180 day period following the effective date of the Registration Statement, subject to the exceptions in FINRA Rule
5110(e)(2).  Additionally, the Private Placement Warrants may not be exercised more than five years from the commencement of sales
of the Public Offering in compliance with FINRA Rule 5110(g)(8)(A).

 

(v)   The
obligation of the Purchaser to purchase and pay for the Private Placement Warrants as provided herein shall be subject to the satisfaction
of the conditions set forth in Section 4 of the Underwriting Agreement, dated the date hereof, by and between the Company, Cantor Fitzgerald
& Co., and Moelis & Company LLC, as a representatives of the underwriters named therein (the “Underwriting Agreement”).

 

Section 2. Representations and Warranties of the Company.

 

As a material inducement
to the Purchaser to enter into this Agreement and purchase the Private Placement Warrants, the Company hereby represents and warrants
to the Purchaser (which representations and warranties shall survive the applicable Closing Date) that:

 

A.    Incorporation
and Corporate Power. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State
of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have
a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite
corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

B.    Authorization;
No Breach.

 

(i)    The
execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized by the Company as of
the applicable Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance with
its terms. Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Private
Placement Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms.

 

    3

    

    

 

(ii)    The
execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement
Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment, of and compliance with, the
respective terms hereof and thereof by the Company, do not and will not as of the applicable Closing Date (a) conflict with or result
in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security
interest, charge or encumbrance upon the Company’s share capital or assets under, (d) result in a violation of, or (e) require any
authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative
or governmental body or agency pursuant to the amended and restated certificate of incorporation of the Company (in effect on the date
hereof or as may be amended prior to completion of the contemplated Public Offering), or any material law, statute, rule or regulation
to which the Company is subject, or any agreement, order, judgment or decree to which the Company is subject, except for any filings required
after the date hereof under federal or state securities laws.

 

C.    Title
to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Warrant Agreement, the Shares issuable
upon exercise of the Private Placement Warrants will be duly and validly issued as fully paid and nonassessable. On the date of issuance
of the Private Placement Warrants, the Shares issuable upon exercise of the Private Placement Warrants shall have been reserved for issuance.
Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title
to the Private Placement Warrants and the Shares issuable upon exercise of such Private Placement Warrants, free and clear of all liens,
claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under the other agreements contemplated hereby,
(ii) transfer restrictions under federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions
of the Purchaser.

 

D.    Valid
Issuance. The total number of shares of all classes of capital stock which the Company has authority to issue is 110,000,000 shares
of common stock (which consist of 100,000,000 shares of the Company’s Class A Common Stock and 10,000,000 shares of the Company’s
Class B common stock, par value $0.0001 per share (the “Class B Common Stock”)) and 1,000,000 shares of the Company’s
preferred stock, par value $0.0001, per share (the “Preferred Stock”). As of the date hereof, the Company has issued
and outstanding no shares of Class A Common Stock, 7,666,667 shares of Class B Common Stock (of which up to 1,000,000 shares are subject
to forfeiture as described in the Registration Statement) and no shares of Preferred Stock. All of the issued shares of capital stock
of the Company have been duly authorized, validly issued, and are fully paid and non-assessable

 

E.    Governmental
Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required
in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any
other transactions contemplated hereby.

 

F.   Regulation
D Qualification. Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers, directors or beneficial
shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d)
of Regulation D under the Securities Act (as defined below).

 

G. Underwriting Agreement. The
representations and warranties of the Company set forth in the Underwriting Agreement are hereby incorporated herein.

 

    4

    

    

 

Section 3. Representations and Warranties of the Purchaser.

 

As a material inducement
to the Company to enter into this Agreement and issue and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents
and warrants to the Company (which representations and warranties shall survive the applicable Closing Date) that:

 

A.    Organization
and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated
by this Agreement.

 

B.    Authorization;
No Breach.

 

(i)    This
Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii)    The
execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser
does not and shall not as of the applicable Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions
or provisions of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.

 

C.    Investment
Representations.

 

(i)    The
Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such
exercise (collectively, the “Securities”), for the Purchaser’s own account, for investment purposes only and
not with a view towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii)    The
Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of
1933, as amended (the “Securities Act”).

 

(iii)    The
Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and
the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv)    The
Purchaser did not enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule
502(c) under the Securities Act.

 

(v)    The
Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to
ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities
involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.

 

    5

    

    

 

(vi)    The
Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made
any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser
nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

(vii)    The
Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance
on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any
other person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with
the terms and conditions of any exemption thereunder. The Private Placement Warrants will bear a legend and appropriate “stop transfer”
instructions (or an appropriate notation if the warrants are issued in book entry form) relating to the foregoing. The Purchaser further
understands that the Securities and Exchange Commission (the “SEC”) has taken the position that promoters or affiliates
of a blank check company and their transferees, both before and after an initial Business Combination, are deemed to be “underwriters”
under the Securities Act when reselling the securities of a blank check company. Based on that position, Rule 144 adopted pursuant to
the Securities Act would not be available for resale transactions of the Securities until the one-year anniversary following consummation
of an initial Business Combination despite technical compliance with the requirements of such Rule.

 

(viii)    The
Purchaser has such knowledge and experience in financial and business matters, knows of the high degree of risk associated with investments
in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment
in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an
indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have
no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can
afford a complete loss of its investment in the Securities.

 

Section 4. Conditions of the Purchaser’s Obligations.

 

The obligations of the Purchaser
to purchase and pay for the Private Placement Warrants are subject to the fulfillment, on or before the applicable Closing Date, of each
of the following conditions:

 

A.    Representations
and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct at and as of the
applicable Closing Date as though then made.

 

B.    Performance.
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before the applicable Closing Date.

 

C.    No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

D.    Warrant
Agreement and Registration and Shareholder Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration
and Shareholder Rights Agreement, in each case on terms satisfactory to the Purchaser.

 

    6

    

    

 

Section 5. Conditions of the Company’s Obligations.

 

The obligations of the Company
to the Purchaser under this Agreement are subject to the fulfillment, on or before the applicable Closing Date, of each of the following
conditions:

 

A.    Representations
and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at and as of
the applicable Closing Date as though then made.

 

B.    Performance.
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before the applicable Closing Date.

 

C.    No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

D.    Warrant
Agreement and Registration and Shareholder Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration
and Shareholder Rights Agreement, in each case on terms satisfactory to the Purchaser.

 

Section 6. Termination.

 

This Agreement may be terminated
at any time after March 31, 2022 upon the election by either the Company or the Purchaser solely as to itself upon written notice to the
other party if the initial closing of the Public Offering does not occur prior to such date.

 

Section 7. Survival of Representations and Warranties.

 

All of the representations
and warranties contained herein shall survive the applicable Closing Date.

 

Section 8. Definitions.

 

Terms used but not otherwise
defined in this Agreement shall have the meaning assigned to such terms in the Registration Statement.

 

Section 9. Miscellaneous.

 

A.    Successors
and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf
of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed
or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement without the prior
written consent of the other party hereto, other than assignments by the Purchaser to affiliates thereof.

 

B.    Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

    7

    

    

 

C.    Counterparts.
This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one
party, but all such counterparts taken together shall constitute one and the same agreement.

 

D.    Descriptive
Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive
part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather than by
limitation.

 

E.    Governing
Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed
in accordance with the internal laws of the State of New York, without regard to the conflicts of laws principles thereof.

 

F.    Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties
hereto.

 

[Signature page follows]

 

    8

    

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	VIRTUOSO ACQUISITION CORP. 2
	 	 
	 	By:	      
	    	 	Name:	Jeffrey D. Warshaw
	 	 	Title:	Chief Executive Officer
	 	 
	 	PURCHASER:
	 	 
	 	CANTOR FITZGERALD & CO.
	 	 
	 	By:	      
	 	 	Name:	 
	 	 	Title:	 

 

[Signature page to Private Placement Warrants
Purchase Agreement]Exhibit 10.10

 

PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT

 

THIS PRIVATE PLACEMENT WARRANTS PURCHASE AGREEMENT,
dated as of [ ], 2022 (as it may from time to time be amended, this “Agreement”), is entered into by and between Virtuoso
Acquisition Corp. 2, a Delaware corporation (the “Company”) and Moelis & Company Group LP (the “Purchaser”).

 

WHEREAS, the Company intends to consummate an initial
public offering of the Company’s units (the “Public Offering”), each unit consisting of one share (each, a “Share”)
of Class A common stock of the Company, par value $0.0001 per share (the “Common Stock”), and one-third of one redeemable
warrant;

 

WHEREAS, each whole warrant entitles the holder to
purchase one Share at an exercise price of $11.50 per Share; and

 

WHEREAS, the Purchaser has agreed to purchase an
aggregate of 166,667 warrants (or up to 191,667 warrants to the extent the underwriters’ over-allotment option is exercised) (the
“Private Placement Warrants”), each Private Placement Warrant entitling the holder to purchase one Share at an exercise
price of $11.50 per Share.

 

NOW, THEREFORE, in consideration of the mutual promises
contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the
parties to this Agreement hereby, intending legally to be bound, agree as follows:

 

AGREEMENT

 

Section 1. Authorization, Purchase and Sale; Terms of the Private
Placement Warrants.

 

A.  Authorization
of the Private Placement Warrants. The Company has duly authorized the issuance and sale of the Private Placement Warrants to the
Purchaser.

 

B.  Purchase
and Sale of the Private Placement Warrants.

 

(i)  Simultaneously
with the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the Company
(the “Initial Closing Date”), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from
the Company, an aggregate of 166,667 Private Placement Warrants at a price of $1.50 per warrant for an aggregate purchase price of $250,000.50
(the “Purchase Price”). Purchaser shall pay the Purchase Price by wire transfer of immediately available funds to the
trust account (the “Trust Account”) maintained by Continental Stock Transfer & Trust Company, acting as trustee
(“Continental”), on the Initial Closing Date. On the Initial Closing Date, upon the payment by the Purchaser of the
Purchase Price, the Company, at its option, shall deliver a certificate evidencing the Private Placement Warrants purchased on such date
duly registered in the Purchaser’s name to the Purchaser or effect such delivery in book-entry form.

 

     

     

    

 

(ii)  In
the event that the underwriters’ over-allotment option is exercised in full or in part, the Purchaser shall purchase up to an additional
25,000 Private Placement Warrants (the “Additional Private Placement Warrants”), in the same proportion as the amount
of the option that is so exercised, and simultaneously with such purchase of Additional Private Placement Warrants, as payment in full
for the Additional Private Placement Warrants being purchased hereunder, and on the date of the closing of such portion of the underwriters’
over-allotment option, Purchaser shall pay $1.50 per Additional Private Placement Warrant, up to an aggregate amount of $37,500.00 by
wire transfer of immediately available funds or by such other method as may be reasonably acceptable to the Company, to the Trust Account.
The closing of the purchase and sale of the Additional Private Placement Warrants, if applicable, shall take place simultaneously with
the closing of all or any portion of the underwriters’ over-allotment option (such closing date, together with the Initial Closing
Date, the “Closing Dates” and each, a “Closing Date”). The closing of the purchase and sale of the
Additional Private Placement Warrants, if applicable, shall take place at the offices of Arnold & Porter Kaye Scholer LLP, counsel
for the Company, or such other place as may be agreed upon by the parties hereto.

 

C.  Terms
of the Private Placement Warrants.

 

(i)  Each
Private Placement Warrant shall have the terms set forth in a Warrant Agreement to be entered into by the Company and Continental in connection
with the Public Offering (the “Warrant Agreement”).

 

(ii)  In
addition to such other terms, conditions and restrictions set forth in the Warrant Agreement and as set forth herein, the Purchaser agrees
that it shall not Transfer (as defined below) any Private Placement Warrants (or shares of Common Stock issued or issuable upon the exercise
of the Private Placement Warrants) until 30 days after the completion of a Business Combination (as defined below) (such 30-day period,
the “Lock-up Period”). Notwithstanding the foregoing, Transfers of the Private Placement Warrants and the shares of
Common Stock issued or issuable upon the exercise thereof and that are held by the Purchaser or any of its permitted transferees are permitted:
(a) to the Company’s officers or directors, any affiliate or family member of any of the Company’s officers or directors,
or to any member(s) of Virtuoso Sponsor 2 LLC (the “Sponsor”) or any affiliates of the Sponsor, Cantor or Group LP;
(b) in the case of an individual, by gift to a member of one of the members of the individual’s immediate family or to a trust,
the beneficiary of which is a member of one of the individual’s immediate family, an affiliate of such person or to a charitable
organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the
case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or Transfers made in connection with the
consummation of an initial Business Combination at prices no greater than the price at which the Shares or Private Placement Warrants
were originally purchased; (f) in the event of the Company’s liquidation prior to the completion of an initial Business Combination;
or (g) in the event of the Company’s liquidation, merger, capital stock exchange, reorganization or other similar transaction which
results in all of its stockholders having the right to exchange their shares of Common Stock for cash, securities or other property subsequent
to the completion of the Business Combination; provided, however, that in the case of clauses (a) through (e), these permitted transferees
must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions herein. For purposes hereof:

 

(A) “Business
Combination” shall mean a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination, involving the Company and one or more businesses; and

 

(B) “Transfer”
shall mean the (1) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise
dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation
with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as
amended, and the rules and regulations of the Securities and Exchange Commission promulgated thereunder with respect to, any security,
(2) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (3) public announcement
of any intention to effect any transaction specified in clause (1) or (2).

 

    2

     

    

 

(iii) On
or prior to the date of effectiveness (the “Effective Date”) of the registration statement relating to the Public Offering
(the “Registration Statement”), the Company and the Purchaser shall enter into a registration and shareholder rights
agreement (the “Registration and Shareholder Rights Agreement”) pursuant to which the Company will grant certain registration
rights to the Purchaser relating to the Private Placement Warrants and the Shares underlying the Private Placement Warrants.

 

(iv) The
Purchaser acknowledges and agrees that the Private Placement Warrants and the related registration rights will be deemed compensation
by the Financial Industry Regulatory Authority (“FINRA”) and will therefore, pursuant to Rule 5110(e) of
the FINRA Manual, be subject to lock-up for a period of 180 days immediately following the commencement of sales of the Public Offering,
subject to FINRA Rule 5110(e)(2). The Private Placement Warrants, the Shares issuable upon the exercise of the Private Placement
Warrants, and the related registration rights may not be sold, transferred, assigned, pledged or hypothecated or be the subject of any
hedging, short sale, derivative, put or call transaction that would result in the economic disposition of such securities by any person
during the foregoing 180 day period following the effective date of the Registration Statement, subject to the exceptions in FINRA Rule
5110(e)(2).  Additionally, the Private Placement Warrants may not be exercised more than five years from the commencement of sales
of the Public Offering in compliance with FINRA Rule 5110(g)(8)(A).

 

(v) The
obligation of the Purchaser to purchase and pay for the Private Placement Warrants as provided herein shall be subject to the satisfaction
of the conditions set forth in Section 4 of the Underwriting Agreement, dated the date hereof, by and between the Company, Cantor Fitzgerald
& Co., and Moelis & Company LLC, as a representatives of the underwriters named therein (the “Underwriting Agreement”).

 

Section 2. Representations and Warranties of the Company.

 

As a material inducement to the Purchaser to enter
into this Agreement and purchase the Private Placement Warrants, the Company hereby represents and warrants to the Purchaser (which representations
and warranties shall survive the applicable Closing Date) that:

 

A.  Incorporation
and Corporate Power. The Company is a corporation duly incorporated, validly existing and in good standing under the laws of the State
of Delaware and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have
a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite
corporate power and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.

 

B.  Authorization;
No Breach.

 

(i)  The
execution, delivery and performance of this Agreement and the Private Placement Warrants have been duly authorized by the Company as of
the applicable Closing Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance with
its terms. Upon issuance in accordance with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Private
Placement Warrants will constitute valid and binding obligations of the Company, enforceable in accordance with their terms.

 

    3

     

    

 

(ii)  The
execution and delivery by the Company of this Agreement and the Private Placement Warrants, the issuance and sale of the Private Placement
Warrants, the issuance of the Shares upon exercise of the Private Placement Warrants and the fulfillment, of and compliance with, the
respective terms hereof and thereof by the Company, do not and will not as of the applicable Closing Date (a) conflict with or result
in a breach of the terms, conditions or provisions of, (b) constitute a default under, (c) result in the creation of any lien, security
interest, charge or encumbrance upon the Company’s share capital or assets under, (d) result in a violation of, or (e) require any
authorization, consent, approval, exemption or other action by or notice or declaration to, or filing with, any court or administrative
or governmental body or agency pursuant to the amended and restated certificate of incorporation of the Company (in effect on the date
hereof or as may be amended prior to completion of the contemplated Public Offering), or any material law, statute, rule or regulation
to which the Company is subject, or any agreement, order, judgment or decree to which the Company is subject, except for any filings required
after the date hereof under federal or state securities laws.

 

C.  Title
to Securities. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Warrant Agreement, the Shares issuable
upon exercise of the Private Placement Warrants will be duly and validly issued as fully paid and nonassessable. On the date of issuance
of the Private Placement Warrants, the Shares issuable upon exercise of the Private Placement Warrants shall have been reserved for issuance.
Upon issuance in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement, the Purchaser will have good title
to the Private Placement Warrants and the Shares issuable upon exercise of such Private Placement Warrants, free and clear of all liens,
claims and encumbrances of any kind, other than (i) transfer restrictions hereunder and under the other agreements contemplated hereby,
(ii) transfer restrictions under federal and state securities laws, and (iii) liens, claims or encumbrances imposed due to the actions
of the Purchaser.

 

D.  Valid
Issuance. The total number of shares of all classes of capital stock which the Company has authority to issue is 110,000,000 shares
of common stock (which consist of 100,000,000 shares of the Company’s Class A Common Stock and 10,000,000 shares of the Company’s
Class B common stock, par value $0.0001 per share (the “Class B Common Stock”)) and 1,000,000 shares of the Company’s
preferred stock, par value $0.0001, per share (the “Preferred Stock”). As of the date hereof, the Company has issued
and outstanding no shares of Class A Common Stock, 7,666,667 shares of Class B Common Stock (of which up to 1,000,000 shares are subject
to forfeiture as described in the Registration Statement) and no shares of Preferred Stock. All of the issued shares of capital stock
of the Company have been duly authorized, validly issued, and are fully paid and non-assessable

 

E.  Governmental
Consents. No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required
in connection with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any
other transactions contemplated hereby.

 

F. Regulation
D Qualification. Neither the Company nor, to its actual knowledge, any of its affiliates, members, officers, directors or beneficial
shareholders of 20% or more of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d)
of Regulation D under the Securities Act (as defined below).

 

G.  Underwriting Agreement. The
representations and warranties of the Company set forth in the Underwriting Agreement are hereby incorporated herein.

 

Section 3. Representations and Warranties of the Purchaser.

 

As a material inducement to the Company to enter
into this Agreement and issue and sell the Private Placement Warrants to the Purchaser, the Purchaser hereby represents and warrants to
the Company (which representations and warranties shall survive the applicable Closing Date) that:

 

A.  Organization
and Requisite Authority. The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated
by this Agreement.

 

    4

     

    

 

B.  Authorization;
No Breach.

 

(i)  This
Agreement constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy,
insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors’
rights and to general equitable principles (whether considered in a proceeding in equity or law).

 

(ii)  The
execution and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser
does not and shall not as of the applicable Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions
or provisions of any agreement, instrument, order, judgment or decree to which the Purchaser is subject.

 

C.  Investment
Representations.

 

(i)  The
Purchaser is acquiring the Private Placement Warrants and, upon exercise of the Private Placement Warrants, the Shares issuable upon such
exercise (collectively, the “Securities”), for the Purchaser’s own account, for investment purposes only and
not with a view towards, or for resale in connection with, any public sale or distribution thereof.

 

(ii)  The
Purchaser is an “accredited investor” as such term is defined in Rule 501(a)(3) of Regulation D under the Securities Act of
1933, as amended (the “Securities Act”).

 

(iii)  The
Purchaser understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration
requirements of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and
the Purchaser’s compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the
availability of such exemptions and the eligibility of the Purchaser to acquire such Securities.

 

(iv)  The
Purchaser did not enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule
502(c) under the Securities Act.

 

(v)  The
Purchaser has been furnished with all materials relating to the business, finances and operations of the Company and materials relating
to the offer and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to
ask questions of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities
involves a high degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed
investment decision with respect to the acquisition of the Securities.

 

(vi)  The
Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made
any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser
nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

 

(vii)  The
Purchaser understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities
laws, and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance
on an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any
other person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with
the terms and conditions of any exemption thereunder. The Private Placement Warrants will bear a legend and appropriate “stop transfer”
instructions (or an appropriate notation if the warrants are issued in book entry form) relating to the foregoing. The Purchaser further
understands that the Securities and Exchange Commission (the “SEC”) has taken the position that promoters or affiliates
of a blank check company and their transferees, both before and after an initial Business Combination, are deemed to be “underwriters”
under the Securities Act when reselling the securities of a blank check company. Based on that position, Rule 144 adopted pursuant to
the Securities Act would not be available for resale transactions of the Securities until the one-year anniversary following consummation
of an initial Business Combination despite technical compliance with the requirements of such Rule.

 

    5

     

    

 

(viii)  The
Purchaser has such knowledge and experience in financial and business matters, knows of the high degree of risk associated with investments
in the securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment
in the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an
indefinite period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have
no current or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can
afford a complete loss of its investment in the Securities.

 

Section 4. Conditions of the Purchaser’s Obligations.

 

The obligations of the Purchaser to purchase and
pay for the Private Placement Warrants are subject to the fulfillment, on or before the applicable Closing Date, of each of the following
conditions:

 

A.  Representations
and Warranties. The representations and warranties of the Company contained in Section 2 shall be true and correct at and as of the
applicable Closing Date as though then made.

 

B.  Performance.
The Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before the applicable Closing Date.

 

C.  No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

D.  Warrant
Agreement and Registration and Shareholder Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration
and Shareholder Rights Agreement, in each case on terms satisfactory to the Purchaser.

 

Section 5. Conditions of the Company’s Obligations.

 

The obligations of the Company to the Purchaser
under this Agreement are subject to the fulfillment, on or before the applicable Closing Date, of each of the following conditions:

 

A.  Representations
and Warranties. The representations and warranties of the Purchaser contained in Section 3 shall be true and correct at and as of
the applicable Closing Date as though then made.

 

    6

     

    

 

B.  Performance.
The Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before the applicable Closing Date.

 

C.  No
Injunction. No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having
authority over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement
or the Warrant Agreement.

 

D.  Warrant
Agreement and Registration and Shareholder Rights Agreement. The Company shall have entered into the Warrant Agreement and the Registration
and Shareholder Rights Agreement, in each case on terms satisfactory to the Purchaser.

 

Section 6. Termination.

 

This Agreement may be terminated at any time after
March 31, 2022 upon the election by either the Company or the Purchaser solely as to itself upon written notice to the other party if
the initial closing of the Public Offering does not occur prior to such date.

 

Section 7. Survival of Representations and Warranties.

 

All of the representations and warranties contained
herein shall survive the applicable Closing Date.

 

Section 8. Definitions.

 

Terms used but not otherwise defined in this Agreement
shall have the meaning assigned to such terms in the Registration Statement.

 

Section 9. Miscellaneous.

 

A.  Successors
and Assigns. Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf
of any of the parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed
or not. Notwithstanding the foregoing or anything to the contrary herein, the parties may not assign this Agreement without the prior
written consent of the other party hereto, other than assignments by the Purchaser to affiliates thereof.

 

B.  Severability.
Whenever possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective
only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.

 

C.  Counterparts.
This Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one
party, but all such counterparts taken together shall constitute one and the same agreement.

 

    7

     

    

 

D.  Descriptive
Headings; Interpretation. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive
part of this Agreement. The use of the word “including” in this Agreement shall be by way of example rather than by
limitation.

 

E.  Governing
Law. This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed
in accordance with the internal laws of the State of New York, without regard to the conflicts of laws principles thereof.

 

F.  Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties
hereto.

 

[Signature page follows]

 

    8

     

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Agreement to be effective as of the date first set forth above.

 

	 	COMPANY:
	 	 
	 	VIRTUOSO ACQUISITION CORP. 2
	 	 
	 	By: 	      
	 	 	Name: 	Jeffrey D. Warshaw
	 	 	Title:	Chief Executive Officer
	 	 
	 	PURCHASER:
	 	 
	 	MOELIS & COMPANY GROUP LP
	 	 
	 	By:	      
	 	 	Name:	 Osamu Watanabe
	 	 	Title:	General Counsel 

 

[Signature page to Private Placement Warrants
Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]